You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement
|
---|---|
Published in |
Respiratory Medicine, February 2015
|
DOI | 10.1016/j.rmed.2015.01.012 |
Pubmed ID | |
Authors |
J. Christian Virchow, Vibeke Backer, Frédéric de Blay, Piotr Kuna, Christian Ljørring, Jesus L. Prieto, Hanne H. Villesen |
Abstract |
Exacerbations are a key outcome in clinical research, providing patient-relevant information about symptomatic control, health state and disease progression. Generally considered as an episode of (sub)acute deterioration of respiratory symptoms, a precise, clinically useful definition is needed for use in clinical trials. |
X Demographics
The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 8 | 42% |
Argentina | 1 | 5% |
Venezuela, Bolivarian Republic of | 1 | 5% |
Unknown | 9 | 47% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 89% |
Scientists | 1 | 5% |
Practitioners (doctors, other healthcare professionals) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Denmark | 1 | 2% |
Germany | 1 | 2% |
Unknown | 58 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 20% |
Other | 11 | 18% |
Student > Ph. D. Student | 6 | 10% |
Student > Master | 5 | 8% |
Student > Bachelor | 4 | 7% |
Other | 11 | 18% |
Unknown | 12 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 39% |
Nursing and Health Professions | 5 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Economics, Econometrics and Finance | 2 | 3% |
Engineering | 2 | 3% |
Other | 10 | 16% |
Unknown | 15 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2016.
All research outputs
#2,480,939
of 25,373,627 outputs
Outputs from Respiratory Medicine
#287
of 3,571 outputs
Outputs of similar age
#33,879
of 360,623 outputs
Outputs of similar age from Respiratory Medicine
#3
of 43 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,571 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,623 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.